Iovance Biotherapeutics, Inc. (FRA:2LB)
2.166
-0.102 (-4.50%)
At close: Jan 30, 2026
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 838 employees as of December 31, 2024. The number of employees increased by 281 or 50.45% compared to the previous year.
Employees
838
Change (1Y)
281
Growth (1Y)
50.45%
Revenue / Employee
€254,698
Profits / Employee
€404,418
Market Cap
852.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 838 | 281 | 50.45% |
| Dec 31, 2023 | 557 | 54 | 10.74% |
| Dec 31, 2022 | 503 | 184 | 57.68% |
| Dec 31, 2021 | 319 | 78 | 32.37% |
| Dec 31, 2020 | 241 | 93 | 62.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Paul Hartmann AG | 10,082 |
| Gelsenwasser AG | 1,898 |
| FRoSTA Aktiengesellschaft | 1,760 |
| Maschinenfabrik Berthold Hermle AG | 1,603 |
| Südwestdeutsche Salzwerke AG | 1,186 |
| EUROKAI GmbH & Co. KGaA | 950 |
| tonies SE | 567 |
| Northern Data AG | 199 |